CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
efficacy with the combination of a next generation anti-CTLA-4 antibody, ONC-392, and anti-PD-1 antibody, pembrolizumab, in platinum resistant ovarian...
Phase 2
Louisville, Kentucky, United States and 20 other locations
The purpose of this study is to assess the safety, tolerability, and efficacy of CBX-12 in female subjects with platinum resistant or refractory ovarian...
Phase 2
Louisville, Kentucky, United States and 16 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Louisville, Kentucky, United States and 176 other locations
This study will evaluate the safety and efficacy of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer (PROC) With C...
Phase 2
Louisville, Kentucky, United States and 73 other locations
Researchers are looking for other ways to treat relapsed high-grade serous ovarian cancer. Relapsed means the cancer came ...
Phase 1, Phase 2
Louisville, Kentucky, United States and 29 other locations
undergoing prospective ophthalmic evaluation with recurrent ovarian cancer (participants with either platinum-sensitive ovarian...
Phase 2
Louisville, Kentucky, United States and 43 other locations
"study drug". The study is focused on participants who have advanced ovarian cancer.The aim of the study is to see how safe, tolera...
Phase 2
Louisville, Kentucky, United States and 54 other locations
(PFS) in women with high-grade, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, expressing hig...
Phase 3
Louisville, Kentucky, United States and 298 other locations
(ZN-c3) in subjects with Platinum-Resistant, High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer. Part 2 of the...
Phase 2
Louisville, Kentucky, United States and 91 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess the s...
Phase 2
Louisville, Kentucky, United States and 67 other locations
Clinical trials
Research sites
Resources
Legal